Cochrane Database of Systematic Reviews

The Cochrane Multiple Sclerosis and Rare Disease of the CNS achived a 2016 Impact Factor of 6.100 (10 publications cited 61 times).

The ten most cited reviews contributing to the 2016 Impact Factor were:

- Neuropsychological rehabilitation for multiple sclerosis - Times Cited: 18

- Exercise therapy for fatigue in multiple sclerosis - Times Cited: 12

- Dimethyl fumarate for multiple sclerosis - Times Cited: 8

- Information provision for people with multiple sclerosis -  Times Cited: 7

- Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis- Times Cited: 7

- Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis - Times Cited: 5

- Telerehabilitation for persons with multiple sclerosis  - Times Cited: 2

- Biologics, colchicine, corticosteroids, immunosuppressants and interferon-alpha for Neuro-Behçet's Syndrome - Times Cited: 1

- Sodium channel blockers for neuroprotection in multiple sclerosis - Times Cited: 1

- Mycophenolate mofetil for relapsing-remitting multiple sclerosis - Times Cited: 0

 

The ten most accessed Cochrane Systematic Reviews in 2016 were:

- Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis- Full text downloads:  3,345

- Exercise therapy for fatigue in multiple sclerosis - Full text downloads: 3,292

- Exercise therapy for multiple sclerosis - Full text downloads: 2,094

- Non pharmacological interventions for spasticity in multiple sclerosis - Full text downloads: 1,849

- Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis - Full text downloads: 1,432

- Neurospychological rehabilitations for multiple sclerosis - Full text downloads: 1,491

- Dietary interventions for multiple sclerosis - Full text downloads: 1,126

- Occupational therapy for multiple sclerosis - Full text downloads: 1,104

- Multidisciplinary ehabilitation for adults with multiple sclerosis - Full text downloads: 1,018

- Rituximab for relapsing-remitting multiple sclerosis - Full text downloads: 982

The highest Altmetric Attention Score from Cochrane Reviews published by our Group in 2016 (score retrieved 30th August 2017) was:

Alemtuzumab for multiple sclerosis - Bloggers: 0; Tweeters: 6;  Facebook: 3;  News outlets: 0